NINTEDONE 150 - Steris Healthcare PVT LTD

May 02, 2024

NINTEDONE 150

Nintedanib (150mg)

NINTEDONE 150 is a medication containing Nintedanib at a strength of 150mg per dose. Nintedanib is a tyrosine kinase inhibitor used in the treatment of various conditions, including idiopathic pulmonary fibrosis (IPF) and certain types of cancer. Let's explore the uses, benefits, and considerations of NINTEDONE 150.

Key Uses and Benefits

Idiopathic Pulmonary Fibrosis (IPF): Nintedanib is approved for the treatment of idiopathic pulmonary fibrosis, a progressive lung disease that leads to scarring and stiffening of lung tissues. Nintedanib helps slow down the progression of IPF and improves lung function.
Non-Small Cell Lung Cancer (NSCLC): Nintedanib, in combination with other medications, is used in the treatment of advanced non-small cell lung cancer that has spread or cannot be removed by surgery. It works by inhibiting pathways involved in tumor growth and angiogenesis.
Other Cancers: Nintedanib may also be prescribed for certain types of ovarian cancer and colorectal cancer, especially in combination with chemotherapy or other targeted therapies.

Dosage and Administration

The recommended dosage of NINTEDONE 150 for idiopathic pulmonary fibrosis is typically one capsule (150mg) taken orally twice daily.
For cancer treatment, the dosage and administration schedule may vary based on the specific type of cancer being treated, the patient's overall health, and other medications being used concurrently. It is important to follow your healthcare provider's instructions regarding dosage and treatment duration.

Conclusion

NINTEDONE 150, containing Nintedanib (150mg), is a valuable medication for the treatment of idiopathic pulmonary fibrosis and certain types of cancer. Its ability to slow down disease progression and improve outcomes in patients with these conditions makes it an important option in healthcare. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.